As of 4:00pm ET
| -0.57 / -3.94%|
The 8 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 18.00, with a high estimate of 30.00 and a low estimate of 14.00. The median estimate represents a +29.40% increase from the last price of 13.91.
The current consensus among 8 polled investment analysts is to Hold stock in Clovis Oncology Inc. This rating has held steady since April, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.